MARKET NEWS

Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
Kinnate Biopharma Inc. Presents Preclinical Data on its Lead FGFR Inhibitor Candidate
Pii Invests in Expansion of Sterile Fill-Finish Capacity & Capabilities
Evelo Biosciences Announces Issuance of US Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines
Decibel Therapeutics Receives Orphan Drug & Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
PolyPid Announces Positive Preclinical Data of its Intra-Tumoral OncoPLEX in Brain Cancer

  FEATURED EDITORIAL

 

  COMPANY PROFILE

Founded in Indianapolis in 2014, Genezen Laboratories is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP vector production, and analytical testing services, building on the company’s expansive knowledge and experience in the industry and working with the nation’s leading institutions. Click here for more.

  EXCLUSIVE ONLINE CONTENT


SomaLogic Announces Strategic Collaboration With UPMC to Tailor Clinical Care Through Proteomics Technology

SomaLogic Announces Strategic Collaboration With UPMC to Tailor Clinical Care Through Proteomics Technology

SomaLogic recently announced a strategic collaboration with leading health system UPMC to explore how the large-scale study of proteins and….

ProQR Announces Axiomer RNA Editing Licensing & Research Collaboration With Lilly

ProQR Announces Axiomer RNA Editing Licensing & Research Collaboration With Lilly

ProQR Therapeutics N.V. recently announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and….

Longeveron Partners With Kinesiometrics to Create & Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell Therapy

Longeveron Partners With Kinesiometrics to Create & Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell Therapy

Longeveron Inc. has entered into an agreement with Kinesiometrics Inc., to provide a cutting-edge, digital data-driven solution for objective real-time measurement of functional capacity and quality….

AzurRx BioPharma Announces Acquisition of First Wave Bio & its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma Announces Acquisition of First Wave Bio & its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma, Inc. recently announced it has entered a definitive agreement to acquire First Wave Bio, Inc. in a stock and cash transaction valued at….

ABITEC Corporation & Larodan AB Announce Brand Refresh After Successful Integration of the Two Companies

ABITEC Corporation & Larodan AB Announce Brand Refresh After Successful Integration of the Two Companies

ABITEC Corporation, an ABF Ingredients company, recently announced in July 2020 the acquisition of Swedish manufacturer and international marketer of state of the art, high-purity research grade lipids, Larodan AB….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 29 – Gene Therapy
October 6 – API Synthesis